Corsens Medical

Company Overview

Snapshot

Founded in August 2013 by Alon Marmor, Corsens Medical operates with 1–10 employees. The company has secured funding across one disclosed round from one investor. In November 2016, Corsens Medical's cardiac monitor received US FDA 510(k) clearance, a significant regulatory milestone for its home-use device.

Business overview

Corsens Medical develops a lightweight, easy-to-operate, early-warning cardiac alert monitor designed for home use. The company's core technology focuses on real-time sensing and remote monitoring to provide early detection of cardiac events. Serving the healthcare industry, particularly providers, Corsens Medical operates within the Health Tech & Life Sciences sector, with a specific focus on Digital Healthcare and Patient Remote Monitoring.

Strategic signal

In November 2016, Corsens Medical achieved a critical regulatory milestone by securing US FDA 510(k) clearance for its cardiac monitor. This approval validated the device's safety and effectiveness, signaling its readiness for commercialization and opening pathways for market entry in the United States. For investors, this indicated a de-risked product with significant market potential in the digital healthcare and remote patient monitoring segments.

Company Intelligence Q&A

What is Corsens Medical's primary product?

Corsens Medical develops a lightweight, simple-to-operate, early-warning cardiac alert monitor for home use.

When was Corsens Medical founded?

Corsens Medical was founded in August 2013.

What significant regulatory approval did Corsens Medical receive?

In November 2016, Corsens Medical's cardiac monitor was granted US FDA 510(k) Pre-Marketing Notification clearance.

What is the current status of Corsens Medical?

Corsens Medical is currently non-active, having ceased to operate in April 2026.